Evidence map›Paper›PMID 34547893›Full record

ArticleBiochemistry2021

Opposing Effects of PhoPQ and PmrAB on the Properties of

Tal Shprung, Naiem Ahmad Wani, Miriam Wilmes, Maria Luisa Mangoni, Arkadi Bitler, Eyal Shimoni, Hans-Georg Sahl, Yechiel Shai

Open access · hybridAbstract read
In one paragraph

Article in Biochemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Development of covalent inhibitors for bacterial histidine kinases.Chemical communications (Cambridge, England) · 2026
    Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Adaptive laboratory evolution ofFrontiers in microbiology · 2023
    Article
  16. Article
  17. Review
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Tal ShprungDepartment of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot 76100, Israel.
Naiem Ahmad WaniDepartment of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot 76100, Israel.
Miriam WilmesPharmaceutical Microbiology Section, Institute for Medical Microbiology, Immunology and Parasitology, University of Bonn, Sigmund-Freud-Strasse 25, D-53127 Bonn, Germany.
Maria Luisa MangoniDepartment of Biochemical Sciences A. Rossi Fanelli, Faculty of Pharmacy and Medicine, Sapienza University of Rome, CU27, 00185 Roma, Italy.ORCID 0000-0002-5991-5868
Arkadi BitlerDepartment of Chemical Research Support, The Weizmann Institute of Science, Rehovot 76100, Israel.
Eyal ShimoniDepartment of Chemical Research Support, The Weizmann Institute of Science, Rehovot 76100, Israel.
Hans-Georg SahlPharmaceutical Microbiology Section, Institute for Medical Microbiology, Immunology and Parasitology, University of Bonn, Sigmund-Freud-Strasse 25, D-53127 Bonn, Germany.
Yechiel ShaiDepartment of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot 76100, Israel.ORCID 0000-0003-4151-5513
Weizmann Institute of Science · ILUniversity of Bonn · DESapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing number of resistant bacteria is a major threat worldwide, leading to the search for new antibiotic agents. One of the leading strategies is the use of antimicrobial peptides (AMPs), cationic and hydrophobic innate immune defense peptides. A major target of AMPs is the bacterial membrane. Notably, accumulating data suggest that AMPs can activate the two-component systems (TCSs) of Gram-negative bacteria. These include PhoP-PhoQ (PhoPQ) and PmrA-PmrB (PmrAB), responsible for remodeling of the bacterial cell surface. To better understand this mechanism, we utilized bacteria deficient either in one system alone or in both and biophysical tools including fluorescence spectroscopy, single-cell atomic force microscopy, electron microscopy, and mass spectrometry (Moskowitz, S. M.;

Indexed as

Antimicrobial Cationic PeptidesBacterial ProteinsCell WallDrug Resistance, BacterialPeriplasmSalmonella entericaSalmonella InfectionsSerogroupAntimicrobial Cationic PeptidesBacterial Proteins

Identifiers

PMID34547893
PMCPMC8638962
OpenAlexW3200530294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.